This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Neuromodulation Market - [Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Gastric Electrical Stimulation (GES), Deep Brain Stimulation (DBS), Sacral Nerve Stimulation (SNS), & Transcranial Magnetic Stimulation (TMS)] - Forecasts To 2017

Gastroparesis

Others

External Neurostimulation

Transcranial Magnetic Stimulation (TMS)

Depression

Tinnitus

Migraine

Stroke

Others

Transcutaneous Electrical Nerve Stimulation (TENS)

Global Neurostimulation Devices Market, by Geography

North AmericaEuropeAsia-PacificRest of the World

TABLE OF CONTENTS

1 INTRODUCTION 16

1.1 KEY TAKE-AWAYS 16

1.2 REPORT DESCRIPTION 16

1.3 MARKETS COVERED 18

1.4 RESEARCH METHODOLOGY 20

1.4.1 MARKET SIZE 20

1.4.2 MARKET SHARE 20

1.4.3 KEY DATA POINTS FROM SECONDARY SOURCES 20

1.4.4 KEY DATA POINTS FROM PRIMARY SOURCES 21

1.4.5 ASSUMPTIONS 21

1.5 STAKEHOLDERS 21

2 EXECUTIVE SUMMARY 22

3 MARKET OVERVIEW 25

3.1 INTRODUCTION 26

3.2 MARKET SEGMENTATION 27

3.3 MARKET DYNAMICS 29

3.3.1 DRIVERS 29

3.3.1.1 Increasing incidence of neurological disorders to spur market growth 29

3.3.1.2 Unprecedented global aging to fuel market growth 29

3.3.1.3 Strong product pipeline to propel the market 30

3.3.1.4 Expanded target applications and new indications are expected to stimulate growth of neuromodulation devices 30

3.3.1.5 Investments and funds – an impetus for market growth 31

3.4 RESTRAINTS 32

3.4.1.1 An unfavourable reimbursement scenario hinders market growth 32

3.4.1.2 Lack of trained professionals likely to hamper market growth 33

3.5 MARKET SHARE ANALYSIS 33

4 GLOBAL NEUROMODULATION MARKET (INTERNAL & EXTERNAL) 35

4.1 INTRODUCTION 36

4.2 INTERNAL STIMULATION 37

4.2.1 SPINAL CORD STIMULATION (SCS) MARKET 37

4.2.1.1 Major applications 39

4.2.1.1.1 Failed back surgery syndrome 40

4.2.1.1.2 Chronic pain 40

4.2.1.1.3 Ischemia 42

4.2.2 DEEP BRAIN STIMULATION (DBS) 42

4.2.2.1 Major applications 45

4.2.2.1.1 Parkinson's disease 46

4.2.2.1.2 Dystonia 47

4.2.2.1.3 Tremor 47

4.2.2.1.4 Alzheimer's 48

4.2.3 SACRAL NERVE STIMULATION (SNS) 48

4.2.3.1 Major applications 51

4.2.3.1.1 Urine incontinence 52

4.2.3.1.2 Fecal incontinence 53

4.2.4 VAGUS NERVE STIMULATION (VNS) 53

4.2.4.1 Major applications 56

4.2.4.1.1 Epilepsy 57

4.2.4.1.2 Others 58

4.2.5 GASTRIC ELECTRICAL STIMULATION (GES) 58

4.3 EXTERNAL STIMULATION 61

4.3.1 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS) 61

3 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs